BIOMARIN PHARMA earnings per share and revenue

BM8 earnings per share for the last quarter are 0.84 CHF whereas the estimation was 0.60 CHF which accounts for 39.21% surprise. Company revenue for the same period amounts to 659.64 M CHF despite the estimated figure of 653.89 M CHF. Estimated earnings per share for the next quarter are 0.70 CHF, and revenue is expected to reach 634.91 M CHF. Also watch annual changes over time to get a bigger picture of BM8 earnings per share and revenue dynamics.